Urinary Creatinin/Protein Ratio in Preterms
PROTI-PREMA
Evolution of the Proteinuria / Creatininuria Ratio in the First Month of Life in the Preterm Infant
1 other identifier
observational
124
1 country
1
Brief Summary
From the first days of life, the newborn presents a "physiological" proteinuria explained by the coexistence of a glomerular and tubular immaturity, all the more marked as the gestational age (GA) is weak. In the child term, proteinuria decreases the first month and its persistence is the marker of kidney damage. The persistence of proteinuria in preterm infants is also considered a marker of renal impairment; however, neither the "physiological" values nor the pattern of urinary excretion of proteins in the first month of life are known. The proteinuria / creatininuria ratio is a validated indicator of proteinuria, as it is correlated with 24-hour urine proteinuria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedFirst Posted
Study publicly available on registry
October 29, 2020
CompletedOctober 29, 2020
October 1, 2020
3 years
October 8, 2019
October 27, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Evolution in time of Ratio of proteinuria / creatininuria
Ratio of proteinuria / creatinine to P1 (D0), P2 (D2 or D3), P3 (D5 or D6), P4 (W2), P5 (W3) and P6 (W4).
Day 0, Day 2 or Day 3, Day 5 or Day 6, Week 2, Week 3, Week 4
Eligibility Criteria
Premature gestational age at birth superior or equal to 32 week of amenorrhea
You may qualify if:
- Premature gestational age at birth superior or equal to 32 week of amenorrhea hospitalized in the intensive care unit or neonatal intensive care unit of the University Hospital of Reunion, southern site, Saint Pierre, in the first 24 hours of life
- Informed consent form Legal representant
You may not qualify if:
- Renal malformation known in antenatal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de La Réunion
Saint-Pierre, La Réunion, 97448, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 8, 2019
First Posted
October 29, 2020
Study Start
January 1, 2017
Primary Completion
January 1, 2020
Study Completion
January 1, 2020
Last Updated
October 29, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share